Advertisement

Topics

Antidote Technologies Ltd Company Profile

02:01 EDT 26th March 2019 | BioPortfolio

Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of participants, Antidote use cutting-edge technology to match the right patients with the right trials. Antidote MatchTM, the company’s unique trial matching engine, currently powers clinical trial search for more than 180 patient communities and health portals — bringing clinical trial awareness, matching, and access to millions of patients a month. Antidote, previously known as TrialReach, is based in the US and UK. For more information, visit www.antidote.me.


News Articles [350 Associated News Articles listed on BioPortfolio]

Recruitment remedy? Antidote teams with direct-to-patient lab to screen clinical trial participants

The digital health company Antidote Technologies is partnering with PWNHealth, a virtual care company that provides direct-to-patient (DTP) lab services.

Many Drugstores Won't Dispense Opioid Antidote as Required

TUESDAY, Nov. 13, 2018 -- People who overdose on opioids have one lifeline, the drug naloxone, but two new studies find that many pharmacies won't offer this lifesaving antidote without a doctor's ble...

Many Drugstores Won't Dispense Opioid Antidote Naloxone as Required

TUESDAY, Nov. 13, 2018 -- People who overdose on opioids have one lifeline, the drug naloxone, but two new studies find that many pharmacies won't offer this lifesaving antidote without a doctor's ble...

Antidote Appoints Dr. Laurent Schockmel as New CEO

Bolstered Leadership Prepares the Company for New Phase of Growth Antidote Technologies, the digital health company that connects patients with medical research, today announc...

Antidote Technologies’ Laurent Schockmel Recognized as a Top 40 Healthcare Transformer

Schockmel will join honor roll of visionaries working to effect much-needed change in the healthcare industry NEW YORK (PRWEB) March 21, 2019 Laurent Schockmel, CEO, Antidote Technologies, has been n...

Potential antidote to botulism

Researchers have identified a compound that strongly inhibits botulinum neurotoxin, the most toxic compound known. That inhibiting compound, nitrophenyl psoralen (NPP), could be used as a treatment to...

Lonza collaborates on commercial supply manufacturing for anti-coagulation antidote

Portola and Lonza will collaborate on commercial supply the API for the formerâs anti-coagulation antidote at Lonzaâs facilities.

What Motivates Patients to Join Clinical Trials: New Research Released by SCORR Marketing and Antidote Technologies

SCORR Marketing, a global health science marketing and communications firm, in partnership with Antidote Technologies, a digital health company, has released an in-depth ...

PubMed Articles [361 Associated PubMed Articles listed on BioPortfolio]

The No-Wrong-Door Approach: Antidote to Boundaries within the American Welfare State.

The Toxin-Antidote Model of Cytoplasmic Incompatibility: Genetics and Evolutionary Implications.

Wolbachia bacteria inhabit the cells of about half of all arthropod species, an unparalleled success stemming in large part from selfish invasive strategies. Cytoplasmic incompatibility (CI), whereby ...

Adoption of Stroke Rehabilitation Technologies by the User Community: Qualitative Study.

Using technology in stroke rehabilitation is attractive. Devices such as robots or smartphones can help deliver evidence-based levels of practice intensity and automated feedback without additional la...

Antidotal Efficacies of the Cyanide Antidote Candidate Dimethyl Trisulfide Alone and in Combination with Cobinamide Derivatives.

Formulation optimization and antidotal combination therapy are the two important tools to enhance the antidotal protection of the cyanide (CN) antidote dimethyl trisulfide (DMTS). The focus of this st...

Application of Digital Technologies in Maxillofacial Prosthetics Literature: A 10-Year Observation of Five Selected Prosthodontics Journals.

To identify trends in the application of various types of digital technologies in maxillofacial prosthetics by identifying these digital technologies and their characteristics and reviewing the preval...

Clinical Trials [501 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Companies [1296 Associated Companies listed on BioPortfolio]

Antidote Technologies Ltd

Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need it. In a w...

Antidote Therapeutics, Inc.

Antidote Therapeutics, Inc. is a biotechnology company with a portfolio of first-in-class nicotine-blocking drugs to treat diseases caused or worsened by nicotine. In addition to...

Neuro-Hitech

Neuro-Hitech is focused specifically on the development and commercialization of next-generation therapies against proven targets for neurodegenerative diseases. The company’s signature offering, Hu...

Bulletin Intelligence

Bulletin Intelligence delivers to senior corporate and government executives fully-customized briefings and dashboards that provide, as one Fortune 100 CEO described it, â...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

More Information about "Antidote Technologies Ltd" on BioPortfolio

We have published hundreds of Antidote Technologies Ltd news stories on BioPortfolio along with dozens of Antidote Technologies Ltd Clinical Trials and PubMed Articles about Antidote Technologies Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Antidote Technologies Ltd Companies in our database. You can also find out about relevant Antidote Technologies Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record